Fezolamine (Win-41528-2) is a drug which was investigated by Sterling as an antidepressant in the 1980s. It acts as a serotonin norepinephrine and dopamine reuptake inhibitor with 3- to 4-fold preference for the former neurotransmitter. It was found to be effective and well tolerated in clinical trials but was never marketed.
This page contains content from the copyrighted Wikipedia article "Fezolamine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
